Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enyu Imai

Showing results (1-10 of 264) with videos related to

Pageof 27
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|January 19, 2012
[Series: Clinical study from Japan and its reflections; Olmesartan Reducing Incidence of Endstage Renal Disease in Diabetic Nephropathy Trial (ORIENT)]Enyu Imai
Nihon Jinzo Gakkai Shi|September 21, 2012
[Beneficial effects of rituximab in the treatment of refractory nephrotic syndrome]Enyu Imai
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Classification of diabetic nephropathy by Japanese Society of Nephrology and Japanse Diabetes Society and KDIGO CKD staging]Enyu Imai
Internal Medicine (Tokyo, Japan)|March 18, 2006
Is ACEI superior to ARB for CKD?Enyu Imai
Nihon Jinzo Gakkai Shi|August 17, 2011
[Membranous nephropathy: up to date]Enyu Imai
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 16, 2008
[Equation for estimating GFR from creatinine in Japan]Enyu Imai
Nature Reviews. Nephrology|August 25, 2009
End-stage renal disease: GFR and albuminuria as predictors: two is better than oneEnyu Imai
Clinical and Experimental Nephrology|November 9, 2012
The coming age of geriatric nephrologyEnyu Imai
Nihon Jinzo Gakkai Shi|May 18, 2012
[Aging and kidney: an epidemiological review]Enyu Imai
International Journal of Urology : Official Journal of the Japanese Urological Association|February 29, 2008
Continuous saga of the side population cells in kidneyEnyu Imai
Pageof 27

Showing results (1-10 of 264) with videos related to

Sort By:
Pageof 27
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|January 19, 2012
[Series: Clinical study from Japan and its reflections; Olmesartan Reducing Incidence of Endstage Renal Disease in Diabetic Nephropathy Trial (ORIENT)]Enyu Imai
Nihon Jinzo Gakkai Shi|September 21, 2012
[Beneficial effects of rituximab in the treatment of refractory nephrotic syndrome]Enyu Imai
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Classification of diabetic nephropathy by Japanese Society of Nephrology and Japanse Diabetes Society and KDIGO CKD staging]Enyu Imai
Internal Medicine (Tokyo, Japan)|March 18, 2006
Is ACEI superior to ARB for CKD?Enyu Imai
Nihon Jinzo Gakkai Shi|August 17, 2011
[Membranous nephropathy: up to date]Enyu Imai
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 16, 2008
[Equation for estimating GFR from creatinine in Japan]Enyu Imai
Nature Reviews. Nephrology|August 25, 2009
End-stage renal disease: GFR and albuminuria as predictors: two is better than oneEnyu Imai
Clinical and Experimental Nephrology|November 9, 2012
The coming age of geriatric nephrologyEnyu Imai
Nihon Jinzo Gakkai Shi|May 18, 2012
[Aging and kidney: an epidemiological review]Enyu Imai
International Journal of Urology : Official Journal of the Japanese Urological Association|February 29, 2008
Continuous saga of the side population cells in kidneyEnyu Imai
Pageof 27